Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,346 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00110019 | Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | completed | Phase 3 | 823 | National Cancer Institute (NCI)NIH | 2 | Oct 19, 2015 | clinicaltrials |
| NCT01253681 | Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer | completed | Phase 1 | 27 | AmgenINDUSTRY | 3 | Oct 14, 2015 | clinicaltrials |
| NCT01632852 | A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission | completed | Phase 1 | 30 | CSL LimitedINDUSTRY | 2 | Oct 9, 2015 | clinicaltrials |
| NCT00229697 | Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study | completed | Phase 2 | 317 | AstraZenecaINDUSTRY | 12 | Oct 5, 2015 | clinicaltrials |
| NCT00391066 | Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)(LUCID) | terminated | Phase 2 | 627 | BiogenINDUSTRY | 23 | Oct 2, 2015 | clinicaltrials |
| NCT01004081 | Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding | completed | Phase 2 | 54 | BiogenINDUSTRY | 4 | Oct 2, 2015 | clinicaltrials |
| NCT00770536 | AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR | completed | Phase 1 | 103 | AmgenINDUSTRY | 3 | Sep 29, 2015 | clinicaltrials |
| NCT00373425 | A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors(RADIANT) | completed | Phase 3 | 1,252 | OSI PharmaceuticalsINDUSTRY | 19 | Sep 17, 2015 | clinicaltrials |
| NCT00427050 | A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel | completed | Phase 2 | 50 | PeplinINDUSTRY | 2 | Sep 14, 2015 | clinicaltrials |
| NCT00659893 | Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 | completed | Phase 1 | 64 | PeplinINDUSTRY | 2 | Sep 14, 2015 | clinicaltrials |
| NCT00057564 | A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma | completed | Phase 3 | 470 | Celgene CorporationINDUSTRY | 16 | Sep 11, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00259922 | Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain | completed | Phase 3 | 485 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 12 | Sep 2, 2015 | clinicaltrials |
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 2 | Sep 1, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT01462695 | Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 3 | Aug 27, 2015 | clinicaltrials |
| NCT01107418 | A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma | completed | Phase 1 | 52 | Hoffmann-La RocheINDUSTRY | 2 | Aug 26, 2015 | clinicaltrials |
| NCT02491892 | A Study of Pertuzumab in Participants With Metastatic Breast Cancer | completed | Phase 2 | 79 | Hoffmann-La RocheINDUSTRY | 8 | Aug 25, 2015 | clinicaltrials |
| NCT00618618 | Phase 2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat | completed | Phase 2 | 73 | Kythera BiopharmaceuticalsINDUSTRY | 3 | Jul 14, 2015 | clinicaltrials |
| NCT00618722 | Phase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat(ATX-101) | completed | Phase 1 / Phase 2 | 85 | Kythera BiopharmaceuticalsINDUSTRY | 3 | Jul 14, 2015 | clinicaltrials |
| NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | completed | Phase 2 | 265 | AVEO Pharmaceuticals, Inc.INDUSTRY | 12 | Jul 8, 2015 | clinicaltrials |
| NCT01103323 | Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy | completed | Phase 3 | 760 | BayerINDUSTRY | 19 | Jun 24, 2015 | clinicaltrials |
| NCT00954746 | Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859 | completed | — | 645 | Endo USA Inc., a Keenova Therapeutics CompanyINDUSTRY | 6 | Jun 16, 2015 | clinicaltrials |
| NCT01309841 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 652 | AstraZenecaINDUSTRY | 4 | Jun 1, 2015 | clinicaltrials |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | terminated | Phase 3 | 14 | AstraZenecaINDUSTRY | 14 | Jun 1, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00056069 | Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia | completed | N/A | 172 | Children's Oncology GroupNETWORK | 6 | May 7, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT00018967 | Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate | completed | N/A | 10 | National Cancer Institute (NCI)NIH | 4 | Apr 30, 2015 | clinicaltrials |
| NCT02016833 | Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity | completed | — | 15 | PX BiosolutionsINDUSTRY | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00020111 | Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 3 | Apr 29, 2015 | clinicaltrials |
| NCT01290783 | Trial of FOLF(HA)Iri Versus FOLFIRI in mCRC(FOLF(HA)iri) | unknown | Phase 3 | 390 | Alchemia OncologyINDUSTRY | 1 | Apr 29, 2015 | clinicaltrials |
| NCT01074697 | Efficacy of Two Antiemetic Regimens in Patients Receiving Radiotherapy and Concomitant Weekly Cisplatin(GAND-emesis) | completed | Phase 3 | 246 | Odense University HospitalOTHER | 4 | Apr 24, 2015 | clinicaltrials |
| NCT02126189 | The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study | unknown | — | 600 | Queensland Centre of Excellence for Head and Neck CancerOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT02156180 | Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma | suspended | — | 13 | Queensland Centre of Excellence for Head and Neck CancerOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT02097875 | Safety Study of a Fluorescent Marker to Visualize Cancer Cells | completed | Phase 1 | 21 | Blaze Bioscience Australia Pty LtdINDUSTRY | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00700063 | A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | completed | Phase 2 | 265 | PeplinINDUSTRY | 2 | Apr 14, 2015 | clinicaltrials |
| NCT00916006 | A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | completed | Phase 3 | 269 | PeplinINDUSTRY | 2 | Apr 2, 2015 | clinicaltrials |
| NCT00940875 | A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Apr 2, 2015 | clinicaltrials |
| NCT00066365 | Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma | completed | Phase 2 | 49 | Children's Oncology GroupNETWORK | 4 | Mar 30, 2015 | clinicaltrials |
| NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)(OPTIMAL) | completed | Phase 3 | 169 | PfizerINDUSTRY | 18 | Mar 30, 2015 | clinicaltrials |
| NCT00254891 | Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer | terminated | Phase 3 | 828 | PfizerINDUSTRY | 26 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT00831844 | Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors | completed | Phase 2 | 116 | National Cancer Institute (NCI)NIH | 3 | Mar 30, 2015 | clinicaltrials |
| NCT00952783 | A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study | completed | — | 98 | PeplinINDUSTRY | 2 | Mar 26, 2015 | clinicaltrials |
| NCT00953732 | A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies | completed | — | 117 | PeplinINDUSTRY | 2 | Mar 26, 2015 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials